Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Titel:
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Auteur:
Llanos-Cuentas, Alejandro Casapia, Martin Chuquiyauri, Raúl Hinojosa, Juan-Carlos Kerr, Nicola Rosario, Maria Toovey, Stephen Arch, Robert H Phillips, Margaret A Rozenberg, Felix D Bath, Jade Ng, Caroline L Cowell, Annie N Winzeler, Elizabeth A Fidock, David A Baker, Mark Möhrle, Jörg J Hooft van Huijsduijnen, Rob Gobeau, Nathalie Araeipour, Nada Andenmatten, Nicole Rückle, Thomas Duparc, Stephan
Verschenen in:
The lancet infectious diseases
Paginering:
Jaargang 18 () nr. 8 pagina's 874-883
Jaar:
2018
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license